Author

Raewyn Calvert

Institution: Breast Cancer Trials

Observed institution: Breast Cancer Trials

OpenAlex ID: A5087705142

Neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant early-stage triple-negative breast cancer (TNBC): A single-arm phase 2 trial.

2022 · Sherene Loi, Prudence A. Francis, et al. · Journal of Clinical Oncology · 20

Phase II study of neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant stage III triple negative breast cancer (TNBC): BCT1702—Survival results.

2024 · Sherene Loi, Prudence A. Francis, et al. · Journal of Clinical Oncology · 7

Works count: 2

Citation count: 27

H-index: 2

I10-index: 1